期刊文献+

肥胖型危、重症甲型H1N1流感8例临床分析 被引量:2

肥胖型危、重症甲型H1N1流感8例临床分析
下载PDF
导出
摘要 目的分析肥胖型甲型H1N1流感患者的临床表现,探讨肥胖在甲型H1N1流感中的作用以及临床治疗特点。方法对南通市区医院确诊的8例肥胖型危重症甲型H1N1流感患者的流行病学资料、临床表现、实验室检查、胸部X线和肺部CT表现进行回顾性分析。结果 8例患者中,男2例(2/8),女6例(6/8),体重指数≥40kg/m2者5例(5/8),≥30kg/m2者3例(3/8)。所有病例均患有一种及以上基础疾病。并发急性肺损伤者1例(1/8),急性呼吸窘迫综合征者3例(3/8),重症肺炎者2例(2/8),双下肢深静脉栓塞者1例(1/8),肺性脑病者1例(1/8)。8例患者均给予抗病毒(奥司他韦75mg或150mg每日2次口服)联合抗感染治疗,应用糖皮质激素治疗者1例(1/8),出现呼吸衰竭者8例(8/8),采用无创呼吸机通气治疗者8例(8/8),后经气管插管行机械通气治疗者2例,胸部X线或肺部CT表现为双肺多肺叶实变影8例(8/8)。结论肥胖患者的肺部特征是甲型H1N1流感病毒和细菌易于感染的基础,合并基础疾病较多,促进病情进展。抗病毒联合抗感染、呼吸机纠正呼吸衰竭是治疗的关键。 Objective To analyze the clinical manifestations of patients in obese patients with Influenza A(H1N1).Investigate the role of obesity in Influenza A(H1N1)and clinical feature of therapies.Methods The epidemiologic data,clinical manifestations,laboratory examination results,and chest X-ray/CT findings of confirmed 8 patients in obesity in our department were retrospectively analyzed.Results Totally 8 cases(2 men and 6 women) were enrolled.The mean age of 8 patients was(57.4±6.7) years,body mass index(BMI) ≥30),3cases,(BMI)≥ 40,5cases.All of cases have one or more than one chronic underlying diseases.complicated with 1 case of acute lung injury(ALI)(1/8),3 case of acute respiratory distress syndrome(ARDS)(3/8),2 cases of severe pneumonia(2/8),1 case of deep vein phlebothrombosis of double lower extremity(1/8),1 case of pulmonary encephalopathy(1/8),8 patients were treated with antiviral therapy(Oseltamivir 75mg,4cases(4/8),150mg,4cases(4/8),oral administration,2 times per day),and anti-bacterial,1cases with hormone therapy(1/8),8patients presenced respiratory failure(8/8),all of cases were treated with mechanical ventilation(8/8),of which 2 cases with mechanical ventilation after endot racheal intubation(2/8).Chest X-ray/CT showed scattered multi-lobe or multi-segment inflammations or large patchy high-density shadow in double lung.Conclusion The feature of lung in obese patients was the base of infected with Influenza A(H1N1) and bacterial,and combined with several underlying diseases were benefit to the pathogenetic condition exacerbations.Anti-viruses combined with anti-bacterial and ventilator using in the respiratory failure state were the critical treatment.
作者 徐雯 张胜利
出处 《当代医学》 2011年第17期121-123,共3页 Contemporary Medicine
基金 南通大学人文社科研究项目(08W042)
关键词 甲型H1N1流感 肥胖 肺炎 Influenza A(H1N1) Pneumonia Obesity
  • 相关文献

参考文献8

  • 1Louie JK,Acosta M,Winter K,et al.Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1)infection in California[J].JAMA,2009,302(17):1896-1902.
  • 2中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3050
  • 4中华人民共和国卫生部.甲型H1N1流感诊疗方案(试用版)[M].3 版.北京:中华人民共和国卫生部办公厅,2009:10-12.
  • 5Ceylan E,Comlekci A,Akkoc A,et al.The effects of body fat distribution on pulmonary function tests in the overweight and obese[J].S Med J,2009,102(1):30-35.
  • 6Díaz E,Rodríguez A,Martin-Loeches L,et al.Impact of obesity in patients infected with new influenza A (H1N1)v.[EB/OL].http://chestjournal.chestpubs.org/content/early/2010/08/04/che st.10-1160,2010-08-05/2010-09-20.
  • 7Ramsey CD,Funk D,Miller III RR,et al.Ventilator management for hypoxemic respiratory failure attributable to H1N1 novel swine origin influenza virus[J].Crit Care Med,2010,38(3):S1-S8.
  • 8Louie J,Jean C,Chen TH,et al.Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A(H1N1)[J].MWR,2009,58(38):1071-1074.

二级参考文献24

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:787
  • 3Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An Asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 4de Roux A,Marcos MA,Garcia E,et al.Viral community-acquired pneumonia in nonimmunocompromised adults.Chest,2004,125:1343-1351.
  • 5Ostrosky-Zeichner L,Alexander BD,Kett DH,et al.Multicenter clinical evaluation of the (1→3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.Clin Infect Dis,2005,41:654-659.
  • 6Food and Drug Administration,HHS.Class Ⅱ Special Controls Guidance Document:serological assays for the detection of betaglucan.Fed Reqist,2004,69:56934-56936.
  • 7Mandell LA,Marrie TJ,Grossman RF,et al.Canadian guidelines for the initial management of community-acquired pneumonia:an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society.The Canadian CommunityAcquired Pneumonia Working Group.Clin Infect Dis,2000,31:383-421.
  • 8Woodhead M,Blasi F,Ewig S,et al.Guidelines for the management of adult lower respiratory tract infections.Eur Respir J,2005,26:1138-1180.
  • 9Mandell LA,Bartlett JG,Dowell SF,et al.Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.Clin Infect Dis,2003,37:1405-1433.
  • 10Fine MJ,Auble TE,Yealy DM,et al.A prediction rule to identify low risk patients with community-acquired pneumonia.N Engl J Med,1997,336:243-250.

共引文献3521

同被引文献82

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部